1967Drug and Therapeutics BulletinRequires access

Bupivacaine

Author information unavailable

Open publisher page 2 citations

Abstract

Bupivacaine (Marcain - DFE), which is advocated as a long-acting local anaesthetic, was synthesised in Sweden in 1957. Chemically bupivacaine and its predecessor mepivacaine (which is not available in this country) are related to lignocaine. Bupivacaine differs from mepivacaine in having a butyl instead of a methyl group attached to the piperidyl ring.

About this research paper

What this paper is about

Bupivacaine (Marcain - DFE), which is advocated as a long-acting local anaesthetic, was synthesised in Sweden in 1957. Chemically bupivacaine and its predecessor mepivacaine (which is not available in this country) are related to lignocaine. Bupivacaine differs from mepivacaine in having a butyl instead of a methyl group attached to the piperidyl ring.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Bupivacaine (Marcain - DFE), which is advocated as a long-acting local anaesthetic, was synthesised in Sweden in 1957. Chemically bupivacaine and its predecessor mepivacaine (which is not available in this country) are related to lignocaine. Bupivacaine differs from mepivacaine in having a butyl instead of a methyl group attached to the piperidyl ring.

Key concepts: Mepivacaine, Bupivacaine, Local anaesthetic, Anesthesia, Medicine, Local anesthetic

Related papers

Back to paper searchBrowse research topicsOriginal source
Bupivacaine — Research Paper | ScholarLens